Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Sylvie Opatrná"'
Autor:
Ladislav Trefil, Sylvie Opatrná, Anna Popperlova, Daniel Lysák, Jaroslav Racek, Ondrej Topolcan, Radka Fuchsova
Publikováno v:
Therapeutic Apheresis and Dialysis. 20:149-157
Icodextrin peritoneal dialysis (PD) solution has been shown to increase interleukin-6 (IL-6) levels in PD effluent as well as leukocyte and mesothelial cell count. Mesothelial cells release cancer antigen 125 (CA125), which is used as a marker of mes
Publikováno v:
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. 35(Suppl 70)
Autor:
Sylvie, Opatrná
Publikováno v:
Vnitrni lekarstvi. 62
Any degree of microinflammation is an independent risk factor for mortality for patients with chronic kidney disease in all stages. During peritoneal dialysis, intraperitoneal activation of inflammation occurs, the degree of which in stable patients
Publikováno v:
Therapeutic Apheresis and Dialysis. 18:309-316
Intraperitoneal glucose degradation products (GDP) load influences systemic advanced glycation end products (AGEs) but the effects on soluble receptor for AGEs (s-RAGE) and its proinflammatory ligands: extracellular newly identified receptor for adva
Publikováno v:
Open Medicine, Vol 7, Iss 5, Pp 604-609 (2012)
The proteins of the fibrinolytic system — urokinase plasminogen activator(uPA), tissue plasminogen activator (tPA)and plasminogen activator inhibitor type IPAI-I) — play important roles in fibrotization in various organs and including peritoneum.
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 32:37-44
Objective In this study, we compared the activity of interleukin-6 (IL-6), a marker of ongoing peritoneal inflammation and biocompatibility, and its other signaling components, the soluble IL-6 receptor (sIL-6R) and soluble Gp130 (sGp130), in periton
Autor:
Ivan Rychlik, Sylvie Dusilova Sulkova, Aneta Hybsova, Vladimir Tesar, Sylvie Opatrná, Lidmila Francová, Ivan Zahradka
Publikováno v:
Nephrology Dialysis Transplantation. 32:iii684-iii685
Publikováno v:
Artificial Organs. 34:420-425
Asymmetric dimethylarginine (ADMA) is a mediator of endothelial dysfunction. Production and elimination of ADMA may be affected by the type of renal replacement therapy used and oxidative stress. Plasma ADMA, advanced glycation end products (AGE), an
Autor:
Sylvie Opatrná, And Vladislav Třeška, Zbyněk Tonar, Ondřej Hes, Věra Křížková, Ludmila Boudova, Jitka Kočová
Publikováno v:
Therapeutic Apheresis and Dialysis. 14:438-441